Literature DB >> 19711396

(1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques.

Matthew L Zierhut1, Esin Ozturk-Isik, Albert P Chen, Ilwoo Park, Daniel B Vigneron, Sarah J Nelson.   

Abstract

PURPOSE: To investigate the signal-to-noise-ratio (SNR) and data quality of time-reduced three-dimensional (3D) proton magnetic resonance spectroscopic imaging ((1)H MRSI) techniques in the human brain at 3 Tesla.
MATERIALS AND METHODS: Techniques that were investigated included ellipsoidal k-space sampling, parallel imaging, and echo-planar spectroscopic imaging (EPSI). The SNR values for N-acetyl aspartate, choline, creatine, and lactate or lipid peaks were compared after correcting for effective spatial resolution and acquisition time in a phantom and in the brains of human volunteers. Other factors considered were linewidths, metabolite ratios, partial volume effects, and subcutaneous lipid contamination.
RESULTS: In volunteers, the median normalized SNR for parallel imaging data decreased by 34-42%, but could be significantly improved using regularization. The normalized signal to noise loss in flyback EPSI data was 11-18%. The effective spatial resolutions of the traditional, ellipsoidal, sensitivity encoding (SENSE) sampling scheme, and EPSI data were 1.02, 2.43, 1.03, and 1.01 cm(3), respectively. As expected, lipid contamination was variable between subjects but was highest for the SENSE data. Patient data obtained using the flyback EPSI method were of excellent quality.
CONCLUSION: Data from all (1)H 3D-MRSI techniques were qualitatively acceptable, based upon SNR, linewidths, and metabolite ratios. The larger field of view obtained with the EPSI methods showed negligible lipid aliasing with acceptable SNR values in less than 9.5 min without compromising the point-spread function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19711396      PMCID: PMC3037114          DOI: 10.1002/jmri.21834

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  28 in total

1.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.

Authors:  Y Zhang; M Brady; S Smith
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

2.  SENSE: sensitivity encoding for fast MRI.

Authors:  K P Pruessmann; M Weiger; M B Scheidegger; P Boesiger
Journal:  Magn Reson Med       Date:  1999-11       Impact factor: 4.668

3.  Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors.

Authors:  S J Nelson
Journal:  Magn Reson Med       Date:  2001-08       Impact factor: 4.668

4.  Sensitivity-encoded spectroscopic imaging.

Authors:  U Dydak; M Weiger; K P Pruessmann; D Meier; P Boesiger
Journal:  Magn Reson Med       Date:  2001-10       Impact factor: 4.668

Review 5.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

6.  Parallel imaging reconstruction using automatic regularization.

Authors:  Fa-Hsuan Lin; Kenneth K Kwong; John W Belliveau; Lawrence L Wald
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

7.  1H NMR chemical shift selective (CHESS) imaging.

Authors:  A Haase; J Frahm; W Hänicke; D Matthaei
Journal:  Phys Med Biol       Date:  1985-04       Impact factor: 3.609

8.  Volumetric proton spectroscopic imaging of mild traumatic brain injury.

Authors:  Varanavasi Govindaraju; Grant E Gauger; Geoffrey T Manley; Andreas Ebel; Michele Meeker; Andrew A Maudsley
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

9.  Measurement of brain glutamate using TE-averaged PRESS at 3T.

Authors:  Ralph Hurd; Napapon Sailasuta; Radhika Srinivasan; Daniel B Vigneron; Daniel Pelletier; Sarah J Nelson
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

10.  Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM.

Authors:  Forrest W Crawford; Inas S Khayal; Colleen McGue; Suja Saraswathy; Andrea Pirzkall; Soonmee Cha; Kathleen R Lamborn; Susan M Chang; Mitchel S Berger; Sarah J Nelson
Journal:  J Neurooncol       Date:  2008-11-15       Impact factor: 4.130

View more
  21 in total

1.  Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models.

Authors:  Erika R Amstalden van Hove; Tiffany R Blackwell; Ivo Klinkert; Gert B Eijkel; Ron M A Heeren; Kristine Glunde
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

2.  Correction and optimization of symmetric echo-planar spectroscopic imaging for hyperpolarized [1-13C]-pyruvate.

Authors:  Zhan Xu; Joshua S Niedzielski; Changyu Sun; Christopher M Walker; Keith A Michel; Samuel A Einstein; Gary V Martinez; James A Bankson
Journal:  J Magn Reson       Date:  2020-10-27       Impact factor: 2.229

3.  Considerations in applying compressed sensing to in vivo phosphorus MR spectroscopic imaging of human brain at 3T.

Authors:  Gokce Hale Hatay; Muhammed Yildirim; Esin Ozturk-Isik
Journal:  Med Biol Eng Comput       Date:  2016-11-08       Impact factor: 2.602

4.  Implementation of 3 T lactate-edited 3D 1H MR spectroscopic imaging with flyback echo-planar readout for gliomas patients.

Authors:  Ilwoo Park; Albert P Chen; Matthew L Zierhut; Esin Ozturk-Isik; Daniel B Vigneron; Sarah J Nelson
Journal:  Ann Biomed Eng       Date:  2010-07-23       Impact factor: 3.934

Review 5.  MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.

Authors:  Kristine Glunde; Lu Jiang; Siver A Moestue; Ingrid S Gribbestad
Journal:  NMR Biomed       Date:  2011-07       Impact factor: 4.044

Review 6.  Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.

Authors:  Sarah J Nelson
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

7.  3D high-resolution imaging of 2-hydroxyglutarate in glioma patients using DRAG-EPSI at 3T in vivo.

Authors:  Zhongxu An; Vivek Tiwari; Jeannie Baxter; Michael Levy; Kimmo J Hatanpaa; Edward Pan; Elizabeth A Maher; Toral R Patel; Bruce E Mickey; Changho Choi
Journal:  Magn Reson Med       Date:  2018-09-14       Impact factor: 4.668

Review 8.  Strategies for rapid in vivo 1H and hyperpolarized 13C MR spectroscopic imaging.

Authors:  Sarah J Nelson; Eugene Ozhinsky; Yan Li; Il woo Park; Jason Crane
Journal:  J Magn Reson       Date:  2013-02-08       Impact factor: 2.229

9.  Fast 3D rosette spectroscopic imaging of neocortical abnormalities at 3 T: Assessment of spectral quality.

Authors:  Claudiu V Schirda; Tiejun Zhao; Victor E Yushmanov; Yoojin Lee; Gena R Ghearing; Frank S Lieberman; Ashok Panigrahy; Hoby P Hetherington; Jullie W Pan
Journal:  Magn Reson Med       Date:  2017-09-14       Impact factor: 4.668

10.  In vivo brain rosette spectroscopic imaging (RSI) with LASER excitation, constant gradient strength readout, and automated LCModel quantification for all voxels.

Authors:  Claudiu V Schirda; Tiejun Zhao; Ovidiu C Andronesi; Yoojin Lee; Jullie W Pan; James M Mountz; Hoby P Hetherington; Fernando E Boada
Journal:  Magn Reson Med       Date:  2015-08-26       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.